These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11489417)

  • 41. Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.
    Murillo-León M; Müller UB; Zimmermann I; Singh S; Widdershooven P; Campos C; Alvarez C; Könen-Waisman S; Lukes N; Ruzsics Z; Howard JC; Schwemmle M; Steinfeldt T
    Nat Commun; 2019 Mar; 10(1):1233. PubMed ID: 30874554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behaviour of Toxoplasma gondii RH Ankara strain tachyzoites during continuous production in various cell lines.
    Döskaya M; Degirmenci A; Ciçek C; Ak M; Korkmaz M; Gürüz Y; Uner A
    Parasitology; 2006 Mar; 132(Pt 3):315-9. PubMed ID: 16318650
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Wang C; Cheng W; Yu Q; Xing T; Chen S; Liu L; Yu L; Du J; Luo Q; Shen J; Xu Y
    Front Immunol; 2018; 9():1222. PubMed ID: 29910815
    [No Abstract]   [Full Text] [Related]  

  • 44. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse.
    Lilue J; Müller UB; Steinfeldt T; Howard JC
    Elife; 2013 Oct; 2():e01298. PubMed ID: 24175088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modification of growth rate of Toxoplasma gondii by continuous passage in immune mice.
    Yano K; Nakabayashi T; Inoki S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):455-63. PubMed ID: 3660982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response.
    Plattner F; Yarovinsky F; Romero S; Didry D; Carlier MF; Sher A; Soldati-Favre D
    Cell Host Microbe; 2008 Feb; 3(2):77-87. PubMed ID: 18312842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Lactate Fermentation Mutant of
    Xia N; Zhou T; Liang X; Ye S; Zhao P; Yang J; Zhou Y; Zhao J; Shen B
    Front Immunol; 2018; 9():1814. PubMed ID: 30147689
    [No Abstract]   [Full Text] [Related]  

  • 48. Proteomics analysis reveals that the proto-oncogene eIF-5A indirectly influences the growth, invasion and replication of Toxoplasma gondii tachyzoite.
    Liu X; Li C; Li X; Ehsan M; Lu M; Li K; Xu L; Yan R; Song X; Li X
    Parasit Vectors; 2021 May; 14(1):283. PubMed ID: 34039408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.
    Ma JS; Sasai M; Ohshima J; Lee Y; Bando H; Takeda K; Yamamoto M
    J Exp Med; 2014 Sep; 211(10):2013-32. PubMed ID: 25225460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the determination of Toxoplasma gondii virulence in mice.
    Saraf P; Shwab EK; Dubey JP; Su C
    Exp Parasitol; 2017 Mar; 174():25-30. PubMed ID: 28153801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxoplasma gondii rhoptry protein38 (TgROP38) affects parasite invasion, egress, and induces IL-18 secretion during early infection.
    Xu Y; Wang X; Liu J; Fu Y; Xu J; Liu Q
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):766-775. PubMed ID: 29961856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
    Lüder CG; Algner M; Lang C; Bleicher N; Gross U
    Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
    Behnke MS; Dubey JP; Sibley LD
    Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High tissue burden of Toxoplasma gondii is the hallmark of acute virulence in mice.
    Hill RD; Su C
    Vet Parasitol; 2012 Jun; 187(1-2):36-43. PubMed ID: 22270034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A conserved apicomplexan microneme protein contributes to Toxoplasma gondii invasion and virulence.
    Huynh MH; Boulanger MJ; Carruthers VB
    Infect Immun; 2014 Oct; 82(10):4358-68. PubMed ID: 25092910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental toxoplasmosis in mice and rabbits. Virulence and cyst formation of Toxoplasma gondii.
    Pettersen EK
    Acta Pathol Microbiol Scand B; 1977 Feb; 85B(1):95-102. PubMed ID: 842354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.
    Tan F; Hu X; Pan CW; Ding JQ; Chen XG
    Parasitol Int; 2010 Jun; 59(2):141-6. PubMed ID: 20056166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.